{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-003236","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2025-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.150968+00:00","generated_at":"2026-05-27T21:26:09.048863+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Sanara MedTech appoints Elizabeth Taylor as CFO, McNeil as Chief Accounting Officer & CAO","bullets":["Elizabeth Taylor appointed CFO effective Jan 15, 2025; base salary $250,000, eligible for annual restricted stock award up to 75% of salary and cash bonus up to 75% of salary.","Michael McNeil assumes roles of Chief Accounting Officer and Chief Administrative Officer; base salary increased to $234,000, bonus eligibility raised to up to 75% of salary.","Taylor joins from Imbed Biosciences where she served as CFO; holds MBA from Harvard and BA from Princeton.","Both executive employment agreements include severance provisions: one year base salary, accelerated stock vesting, and COBRA reimbursement upon qualifying termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-003236","json":"https://secwatch.observer/filing/0001493152-25-003236.json","markdown":"https://secwatch.observer/filing/0001493152-25-003236.md","text":"https://secwatch.observer/filing/0001493152-25-003236.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315225003236/0001493152-25-003236-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315225003236/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T21:26:09.048863+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e900fdf7bf","claim":"Elizabeth B. Taylor was appointed as Chief Financial Officer at Sanara MedTech Inc..","evidence_excerpt":"On January 15, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Elizabeth B. Taylor to serve as the Chief Financial Officer of the Company, including the role of principal financial officer, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315225003236/0001493152-25-003236-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}